Navigation Links
Anthrax inhibitor counteracts toxin, may lead to new therapeutics

Researchers from Rensselaer Polytechnic Institute and the University of Toronto have designed a nanoscale assembly of molecules that successfully counteracts and inhibits anthrax toxin in animal and laboratory experiments. The novel approach used to neutralize anthrax toxin could be applied in designing potent therapeutics for a variety of pathogens and toxins, according to the researchers.

Anthrax toxin, secreted by the anthrax bacterium, is made of proteins and toxic enzymes that bind together to inflict damage on a host organism. The inhibitor, which is described by the Rensselaer-Toronto team in the April 23 online edition of the journal Nature Biotechnology, works by preventing the assembly of toxic enzyme components, thereby blocking the formation of fully assembled anthrax toxin and neutralizing its activity.

The inhibitor protected rats from anthrax toxin in the study.

"Our eventual goal is to use the inhibitor as a human therapeutic for anthrax exposure, one that can stop the toxin from functioning inside the body," says Ravi Kane, the Merck Associate Professor of Chemical and Biological Engineering at Rensselaer and a principal investigator of the project. "Combining the inhibitor with antibiotic therapy may increase the likelihood of survival for an infected person."

The 2001 intentional release of anthrax spores via postal mail in the United States led to increased research on possible therapeutics and vaccines to treat toxins that could be used as biological weapons. The current treatment for anthrax exposure is antibiotics, but inhalation anthrax still has a fatality rate of 75 percent even after antibiotics are given, according to the Centers for Disease Control and Prevention. Antibiotics slow the progression of infection by targeting the bacteria, but do not counter the advanced destructive effects of anthrax toxin in the body.

Anthrax toxin is a polyvalent protein complex in that it displays multiple copies of
'"/>

Source:Rensselaer Polytechnic Institute


Page: 1 2 3

Related biology news :

1. Study Models Impact Of Anthrax Vaccine
2. Anthrax test, developed by army and CDC, receives FDA approval
3. Anthrax inhibitors identified by Burnham team
4. Anthrax stops body from fighting back, study shows
5. Anthrax spores may survive water treatment
6. Anthrax attack posed greater potential threat than thought
7. Anthrax paralyzes immune cells with lethal toxin, UF research shows
8. Protease inhibitors reach beyond HIV
9. UNC scientists discover new role for protein as fundamental inhibitor of cell movement
10. Small molecule inhibitor of cholera discovered
11. Enzyme inhibitors block replication of SARS virus
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Anthrax inhibitor counteracts toxin may lead new therapeutics

(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
(Date:5/8/2015)... -- Synaptics Inc. (NASDAQ: SYNA ), the leading developer ... executive management team will present at the following investor events: ... Conference Date: May 18, 2015 Time: 10:40am ET ... Cowen and Company Technology, Media & Telecom ... New York Palace Hotel, New York, NY ...
(Date:5/6/2015)... AVIV, Israel , May 6, 2015 ... world,s most established helmet producer, announced today that they ... Smart Helmet, the world,s first bio-sensing cycling helmet and ... be released in two new colors in order to ... for the product. In addition, LifeBEAM and Lazer announced ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... in the forthcoming issue of The American Naturalist, Tom ... Louda (all of the University of Nebraska, Lincoln) examined ... the same rate. , Plant-insect ecologists typically attribute ... defective chemistry of plant tissues. However, the researchers found ...
... play an important role in longevity, with longer-lived rodents ... speeds metabolism, a new study has found. , The ... animal's metabolism, the shorter its life, and vice versa, ... releases hormones that regulate metabolic rate. , "Thyroid ...
... the international Census of Marine Life (CoML), a team ... to explore coral reef biodiversity in the largest fully ... Marine National Monument. Led by the National Oceanic ... with funding from NOAA's Coral Reef Conservation Program and ...
Cached Biology News:Longer-lived rodents have lower levels of thyroid hormone 2First Biodiversity Census of coral reef ecosystems in the NW Hawaiian Islands 2First Biodiversity Census of coral reef ecosystems in the NW Hawaiian Islands 3
(Date:5/26/2015)... - Fluorinov Pharma (Fluorinov), a FACIT portfolio company, today ... to its Board of Directors.  His appointment strengthens Fluorinov,s ... Fluorinov accelerates its clinical development activities.  ... pleasure to welcome Luke to the Board of Directors.  ... financial strength and success of multiple organizations," said ...
(Date:5/26/2015)... Boston, MA (PRWEB) May 26, 2015 ... that addresses a long-standing unmet biomedical need does not ... to a problem that has seen many prior failures ... to gaining acceptance and use is an irony that ... As a small, new start-up company, Asymmetrex ...
(Date:5/25/2015)... Tel Aviv, Israel (PRWEB) May 25, 2015 ... and analytics software provider, announced the availability, beginning ... , The new version of Phenome One solidifies Phenome ... novel user interface supporting a simple and intuitive breeding ... faster performance; the ability to customize field design, and ...
(Date:5/22/2015)... 2015 Knowledgent , the data ... explores the potential of big data analytics in the ... developed to help life sciences and healthcare organizations understand ... gain critical business insights. , The life sciences and ... driven by patient profiling, compliance and regulatory requirements, and ...
Breaking Biology Technology:Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 2Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 3In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 2In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 3Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 2Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 3New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2
... Calif., May 22 Clarient, Inc.,(Nasdaq: CLRT ... services,resource for pathologists, oncologists and the pharmaceutical industry,today ... Financial Officer,Jim Agnello, will step down from that ... as Chief Financial Officer until his successor is,appointed ...
... may look like ordinary washers and dryers to you, but ... future. , In the laundry room at the University ... Residents can go online to check which washers and dryers ... when a machines cycle is finished. The company that maintains ...
... Pharmaceutical,Services, Inc. (NYSE: WST ) today announced that ... and Treasurer will,be presenting at the 2008 UBS Global ... May 28, 2008 in London., A copy of ... link of the Company,s website at http://www.westpharma.com ...
Cached Biology Technology:Jim Agnello to Resign as Clarient Chief Financial Officer 2Jim Agnello to Resign as Clarient Chief Financial Officer 3Jim Agnello to Resign as Clarient Chief Financial Officer 4Better business decisions with real-time data 2Better business decisions with real-time data 3West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference 2
Edited by D.M. Gersten (1996) Provides comprehensive descriptions of the techniques available for analytical gel electrophoresis of proteins and offers clear step-by-step protocols for all of the m...
... Edited by John M. Walker ... highly successful analytical techniques for studying ... tested protocol contains detailed, step-by-step instruction, ... explanations and comprehensive lists of reagents ...
...
ANTI S. ENT TOX BC2D...
Biology Products: